🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to evaluate whether hypofractionated who...
Status
Recruiting
Location
Siriraj Hospital
Start Date
2026-08-03
Trial ID
NCT07709650
Treatments Being Tested
Nelfinavir will increase the efficacy of Cisplatin based chemo- radiation t...
Status
Completed
Location
University of Miami
Start Date
2012-01
Trial ID
NCT01485731
Prospective cohort study comparing robot-assisted radical prostatectomy and...
Status
Recruiting
Location
Noordwest Ziekenhuisgroep
Start Date
2023-02-16
Trial ID
NCT05931419
The purpose of this trial is to compare two similar treatments for patients...
Status
Unknown
Location
BC Cancer Agency
Start Date
2004-05
Trial ID
NCT00175396
To observe the efficacy and safety of hydrochloride anlotinib combined with...
Status
Unknown
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05772377
Treatments Being Tested
The researchers plan: * To undertake clinical studies of radiotherapy with...
Status
Unknown
Location
Dept. of Atomic Energy, Tata Memorial Centre
Start Date
2004-12
Trial ID
NCT00122746
Treatments Being Tested
This will be the first study to assess the clinical feasibility of dose esc...
Status
Completed
Location
Saint Bartholomew's Hospital
Start Date
2010-07
Trial ID
NCT01230996
Treatments Being Tested
The purpose of this study is to find out whether combining a shorter than s...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2021-10-19
Trial ID
NCT05100472
The purpose of this study is to see what amount of radiation is safe to giv...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge (Follow Up Only)
Start Date
2014-07
Trial ID
NCT02199236
Treatments Being Tested
This phase III trial compares whether the addition of pembrolizumab to radi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-04-09
Trial ID
NCT04214067